Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 8 recruiting now later-stage tilt

Pelvic Organ Prolapse: later-stage trial registry

8 of 41 indexed Pelvic Organ Prolapse trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #357 of 28,707 conditions by registered trial count.

41 US clinical trials · 8 currently recruiting · #357 of 28,707 conditions by registered trial count

Pelvic Organ Prolapse: 41 US clinical trials tracked, 8 recruiting.

Pelvic Organ Prolapse is the subject of 41 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 3 of these trials.

Enrollment posture brief

Registry condition pelvic-organ-prolapse

OPEN 8 | RECR 20% | LATE 4 | EARLY 0 | RANK #357 | SPON 3

Nearest open-share peer: Anaplastic Large Cell Lymphoma (19% recruiting · 26 trials)

Gastroesophageal Junction Ad58.5%Depression, Anxiety51.2%Pelvic Organ Prolapse (this)20%Dyslipidemia17.1%Acute Coronary Syndrome14.6%
Open-enrollment share among volume-matched conditions near Pelvic Organ Prolapse

Pelvic Organ Prolapse lists 8 open slots (20% of 41 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pelvic Organ Prolapse on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pelvic Organ Prolapse is recruiting below its size-band peers.

    8 of 41 indexed trials (19.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Pelvic Organ Prolapse trials is spread across many organizations.

    Mayo Clinic accounts for 3 of 41 trials (7.3%). 33 distinct sponsors appear on at least one study for this condition label.

  3. Typical Pelvic Organ Prolapse enrolment sits around 103 participants.

    Median target enrolment is 103 among the 41 trials that report a genuine target (sentinel values excluded). 18 of those (43.9%) plan for fewer than 100 participants.

  4. Pelvic Organ Prolapse splits between interventional and observational designs.

    26 interventional and 15 observational studies make up this index (63.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 32Phase 42

Open and recent trials

41 total, page 1 of 1

RECRUITING 1,000 participants

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

Ethicon

NCT04829175

RECRUITING NA 288 participants

The AccelERate Trial

NICHD Pelvic Floor Disorders Network

NCT07218016

RECRUITING NA 182 participants

POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment

Medstar Health Research Institute

NCT06634459

RECRUITING NA 112 participants

SORE Study: Sitz Baths After Urogynecologic Reconstruction

Yale University

NCT07215780

RECRUITING NA 110 participants

Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy

University of Alabama at Birmingham

NCT07008898

RECRUITING 106 participants

Centered Surgery - Preoperative Counseling and Patient Satisfaction

The Cleveland Clinic

NCT07471464

RECRUITING 100 participants

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

Ethicon

NCT04829058

RECRUITING 30 participants

Pessary Experience Study

University of Virginia

NCT06021769

ACTIVE NOT RECRUITING NA 420 participants

EASE: The Materna Prep Pivotal Study

Materna Medical

NCT03973281

ACTIVE NOT RECRUITING NA 142 participants

Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery

Brigham and Women's Hospital

NCT03522961

ACTIVE NOT RECRUITING NA 112 participants

SCP vs HUSLS for Pelvic Organ Prolapse Repair

Loma Linda University

NCT02800512

ACTIVE NOT RECRUITING 80 participants

Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse

Mayo Clinic

NCT04179955

ACTIVE NOT RECRUITING NA 60 participants

Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

University of Alabama at Birmingham

NCT05731284

ACTIVE NOT RECRUITING NA 53 participants

Clinical Investigation of the da Vinci Surgical System

Intuitive Surgical

NCT05682742

ACTIVE NOT RECRUITING NA 30 participants

Vaginal Orthosis Use After Vaginal Reconstructive Surgery

University of Alabama at Birmingham

NCT05812859

COMPLETED 316 participants

Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy

Atlantic Health System

NCT02248935

COMPLETED NA 285 participants

The Extended Operations And Pelvic Muscle Training In The Management Of Apical Support Loss Study

NICHD Pelvic Floor Disorders Network

NCT01166373

COMPLETED 210 participants

Race, Ethnicity, Socioeconomic Status and Prolapse-rElated Decisional ConflicT

Women and Infants Hospital of Rhode Island

NCT04977141

COMPLETED 202 participants

Predictors of Recovery Expectancy

Indiana University

NCT04274491

COMPLETED 158 participants

Validation of Transvaginal Tactile Imaging

Artann Laboratories

NCT01491334

COMPLETED Phase 4 154 participants

Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery

Halina M Zyczynski, MD

NCT02727322

COMPLETED 152 participants

Colpocleisis for Advanced Pelvic Organ Prolapse

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NCT00271037

COMPLETED 132 participants

Predictors of Post Operative Morbidity in Older Women With Pelvic Organ Prolapse

University of Pennsylvania

NCT01967446

COMPLETED NA 114 participants

Pelvic Floor Disorder Assessment of Knowledge and Symptoms: an Educational Model in Spanish-Speaking Women

Johns Hopkins University

NCT04829721

COMPLETED NA 110 participants

Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery

Yale University

NCT03539107

COMPLETED Phase 4 110 participants

Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery

Joseph Kowalski

NCT05658887

COMPLETED 103 participants

Caregiver Support and Post-operative Convalescence

Icahn School of Medicine at Mount Sinai

NCT04897061

COMPLETED NA 100 participants

The Purpose of This Study is to Look at Pelvic Support Problems, Also Commonly Known as Pelvic Organ Prolapse

University of Oklahoma

NCT00964197

COMPLETED NA 94 participants

Impact of Level III Support Procedure on Enlarged Genital Hiatus After Minimally Invasive Sacrocolpopexy

University of Pittsburgh

NCT04480671

COMPLETED NA 84 participants

Abdominal Colpopexy: Comparison of Endoscopic Surgical Strategies

Loyola University

NCT01124916

COMPLETED NA 78 participants

Feasibility Study of the Reia Vaginal Pessary

Reia

NCT04508335

COMPLETED 74 participants

Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study

Coloplast A/S

NCT01541748

COMPLETED NA 72 participants

Pudendal Nerve Block in Vaginal Surgery

MetroHealth Medical Center

NCT04198714

COMPLETED Phase 3 66 participants

Lidocaine for Pessary Check Pain Reduction

University of South Florida

NCT05493735

COMPLETED NA 64 participants

Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery

The Cleveland Clinic

NCT03048682

COMPLETED Phase 3 63 participants

Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP

TriHealth

NCT02073734

COMPLETED 63 participants

EVeRLAST 2-Year Follow-Up

Duke University

NCT05542836

COMPLETED NA 58 participants

Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use

Mayo Clinic

NCT02680145

COMPLETED NA 52 participants

Analysis of Procedural Times Using Colpassist for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial

University of North Carolina, Chapel Hill

NCT02367235

COMPLETED NA 51 participants

Perineorrhaphy Outcomes Related to Body Imagery

University of New Mexi

NCT02548858

COMPLETED 18 participants

Advanced Biomarker Assessment in Pelvic Organ Prolapse

Mayo Clinic

NCT03642054

Phase Distribution

PhaseTrial count
Phase 3 2
Phase 4 2

Named interventions

Most-linked intervention names on Pelvic Organ Prolapse records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Intervention Device
2 trials
Placebo Drug
2 trials
Colpassist vaginal positioning device Procedure
1 trials
Traditional vaginal positioning device Procedure
1 trials
sling or other to treat or prevent stress incontinence Procedure
1 trials
Colpocleisis prolapse repair surgery Procedure
1 trials
Foley catheter - Late Voiding Trial Device
1 trials
Foley catheter - Early Voiding Trial Device
1 trials

US sites by state

Facility locations filed on Pelvic Organ Prolapse trials. A trial with sites in several states counts in each.

Pennsylvania 11 trials
North Carolina 8 trials
Alabama 8 trials
Ohio 6 trials
California 6 trials
Illinois 5 trials
Florida 5 trials
Texas 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pelvic Organ Prolapse page

41 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 8 Pelvic Organ Prolapse trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mayo Clinic sponsors the most Pelvic Organ Prolapse trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pelvic Organ Prolapse condition card totals 41 registered trials; most-linked intervention Intervention; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.